Table 1.
General characteristics of population.
| Overall population | n = 43 | |
|---|---|---|
| Demographics | Male gender – n (%) | 31 (72) |
| Age (years) median (IQR) | 61 (51.5–69.5) | |
| Comorbidities, n (%) | 34 (79) | |
| Chronic liver disease | 0 | |
| Chronic kidney disease | 1 (2.3) | |
| Immunocompromised patients | 3 (7) | |
| Chronic heart failure | 5 (11.6) | |
| Diabetes mellitus | 9 (20.9) | |
| Respiratory disease | 13 (30.2) | |
| Hypertension | 25 (58.1) | |
| BMI, median (IQR) | 27.9 (25.2–31) | |
| Viral characteristics | Duration of symptoms before ICU admission (days), median (IQR) | 9 (6–11) |
| Length of hospital stay before ICU admission (days) median (IQR) | 1 (0–2) | |
| Chest computed tomographya, n (%) | ||
| Compatible | 34 (97.1) | |
| Crazy paving | 21 (61.8) | |
| Consolidation | 30 (88.2) | |
| Ground glass opacification | 33 (97) | |
| Extensive | ||
| < 25% | 13 (39.4) | |
| [25–50] % | 12 (36.3) | |
| [51–75] % | 6 (18.2) | |
| > 75% | 2 (6) | |
| One specific treatmentb, n (%) | 30 (69.7) | |
| Lopinavir/ritonavir | 27 (90) | |
| Hydroxychloroquine | 3 (10) | |
| Corticosteroids, n (%) | 9 (21) | |
| Length of ICU stay before corticosteroids (days) median (IQR) | 2 (0–3) |
BMI: body mass index.
a
Data are available for 35 of 43 included patients.
b
Patients admitted with one specific treatment: 27 (90%).